[A coronary atherosclerosis course in patients after interventions on coronary arteries]

Klinichna Khirurhiia
|August 31, 2013
PubMed

Insights

This study analyzed coronary atherosclerosis progression in 283 patients following coronary stenting or shunting procedures. Coronary angiography revealed the long-term outcomes of these interventions on coronary artery disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
  • Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are primary revascularization strategies.
  • Long-term outcomes and disease progression after these interventions require continuous investigation.

Purpose of the Study:

  • To evaluate the long-term course of coronary atherosclerosis in patients who underwent coronary stenting or shunting.
  • To analyze the effectiveness of coronary interventions in managing advanced coronary artery disease.
  • To identify factors influencing disease progression post-intervention.

Main Methods:

  • Retrospective analysis of coronaroventriculography data from 283 patients.
  • Inclusion of patients who received either coronary stenting or coronary shunting.
  • Follow-up assessment of coronary artery patency and progression of atherosclerotic lesions.

Main Results:

  • Detailed analysis of post-intervention coronary angiograms.
  • Assessment of restenosis rates and new lesion development.
  • Comparison of outcomes between stenting and shunting procedures, where applicable.

Conclusions:

  • Interventions like coronary stenting and shunting significantly alter the course of coronary atherosclerosis.
  • Understanding long-term angiographic outcomes is crucial for optimizing patient management.
  • Further research can refine treatment strategies based on observed disease progression patterns.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...